Search Results
Search results for "early-career scientists"
Results found for "early-career scientists"
- Tectonic Therapeutic Strengthens Leadership Team
today announced the promotion of Senior Vice President, Head of Research, Peter McNamara, PhD, to Chief Scientific
- Molecular insights into psychedelic drug action
August 2022 "A confluence of factors has renewed interest in the scientific understanding and translational
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
These scientists come from diverse fields such as medicine, agriculture, industrial chemicals, and data
- 📰 GPCR Weekly News
GPCR Industry News Septerna Announces the Formation of a Cross-Functional Scientific and Drug Discovery Diabetes and Obesity Special report 2022: Meet 20 women blazing trails in biopharma R&D ERNEST - 2022 Scientific
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie
- Pharmacologic Models
How the Mass Action Law underpins nearly every model Future of Receptor Theory: Linkage vs.
- Profiling Immune Cell and Platelet Transcriptomes
A study published in Scientific Data by Arne Hansen et a l has introduced a sensitive method for detecting
- New role of β-arrestins in MOR signaling
opioid overdose in the U.S., combatting the opioid overdose epidemic has become a mean challenge for the scientific According with the National Institute on Drug Abuse (NIDA) nearly 92, 000 Americans died from drug-involved
- Four Reasons to Measure GPCR Signaling Bias in Drug Discovery
Programs that characterize signaling bias early — across G protein, β-arrestin, and second messenger
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
dissociation kinetics of ligands targeting G-protein-coupled receptors "Recently, academic and industrial scientific
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
Prof Pfleger has served on the ASCEPT Board since 2016 and was Chair of the Scientific Advisory Committee
- Newly launched antibody libraries put hard-to-drug targets within reach
Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates.
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis  sativa , Scientifi
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
The Problem: Hundreds of Receptors, Almost No Ligands Alessandro’s work focuses on olfactory GPCRs—nearly
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
Richard is the architect behind nearly all of Exscientia's partnerships and collaborations across pharma
- Advantages of Fluorescent Probes in GPCR Assays
Our scientific team can guide you choose or design the right fluorescent ligand for your research. Â
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
Scientific Reports , 7 (1), 16012. Fowler, D. M., & Fields, S. (2014).
- 📰 GPCR Weekly News, September 4 to 10, 2023
2023 | GPCR Retreat November 15 - 17, 2023 | MPGPCR Conference November 20 - 23, 2023 | ASCEPT Annual Scientific
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
This situation is now evolving, with recent scientific and technological breakthroughs encouraging a Spurred on by new scientific and technological advances related to the understanding of structure and There is a great deal of scientific and business interest in solving this problem, and the last two years
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
The G protein-coupled receptors (GPCRs) are the largest family of membrane receptors, with nearly 800
- Odorant receptors – a bit of smell for drug discovery
the identified ligands being often synthetic compounds, there has been a growing interest from the scientific
- Overview of adhesion GPCRs self-activation
Fortunately, the scientific community has become increasingly interested in studying these proteins and
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Their abundance and role in nearly all physiological systems make GPCR the largest protein family targeted
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
Scientific Reports . (16)     Laasfeld, T.; Ehrminger, R.; Tahk, M.-J.; Veiksina, S.; Kõlvart, K.










